The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting

G W Hanlon1

  • 1School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton, UK. g.w.hanlon@brighton.ac.uk

Insights

Acinetobacter species are increasingly causing dangerous hospital infections. Their growing antibiotic resistance suggests we may be nearing the end of effective treatments for these resilient bacteria.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Acinetobacter species are significant causes of hospital-acquired infections.
  • These infections are linked to substantial patient illness and death.
  • Emerging resistance patterns in Acinetobacter pose a serious threat to public health.

Purpose of the Study:

  • To highlight the growing threat of Acinetobacter infections.
  • To discuss the implications of Acinetobacter's antibiotic resistance.
  • To emphasize the urgency of addressing Acinetobacter as a major nosocomial pathogen.

Main Methods:

  • Literature review of recent studies on Acinetobacter infections.
  • Analysis of trends in nosocomial infections caused by Acinetobacter.
  • Assessment of antibiotic resistance data for Acinetobacter species.

Main Results:

  • Acinetobacter is a leading cause of nosocomial infections.
  • Significant morbidity and mortality are associated with these infections.
  • Antibiotic resistance in Acinetobacter is rapidly developing.

Conclusions:

  • Acinetobacter poses a critical challenge in healthcare settings.
  • The rise in resistance suggests a potential end to the antibiotic era for Acinetobacter.
  • Urgent strategies are needed to combat Acinetobacter infections and resistance.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Antibiotic Selection00:57

Antibiotic Selection

Overview